Identity
- Security key
- 19645
- Ticker
- ONCO
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2022-02-18
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- ONCO
Detail
Enriched 2026-08-14 20:47
- Market cap
- $3,291,334.27
- Shares outstanding (class)
- 3,691,492
- Shares outstanding (weighted)
- 3,691,492
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 2
- Location
- CINCINNATI, OH
- Homepage
- https://www.onconetix.com
- Description
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
Market cap and share counts drift.